Here, we describe the cytotoxic and antitumor effect of these two novel nanotoxins, T22-PE24-H6 and T22-DITOX-H6 that specifically target CXCR4+ cells, for the treatment of HNSCC. Here, CXCR4 is linked to head and neck squamous cell carcinoma.